JP2025504706A5 - - Google Patents
Info
- Publication number
- JP2025504706A5 JP2025504706A5 JP2024537409A JP2024537409A JP2025504706A5 JP 2025504706 A5 JP2025504706 A5 JP 2025504706A5 JP 2024537409 A JP2024537409 A JP 2024537409A JP 2024537409 A JP2024537409 A JP 2024537409A JP 2025504706 A5 JP2025504706 A5 JP 2025504706A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- udenafil
- pharmaceutically acceptable
- acceptable salt
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163291858P | 2021-12-20 | 2021-12-20 | |
| US63/291,858 | 2021-12-20 | ||
| PCT/US2022/000033 WO2023121689A1 (en) | 2021-12-20 | 2022-12-20 | Methods and compositions for improving exercise performance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504706A JP2025504706A (ja) | 2025-02-17 |
| JP2025504706A5 true JP2025504706A5 (https=) | 2025-12-22 |
Family
ID=85382567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537409A Pending JP2025504706A (ja) | 2021-12-20 | 2022-12-20 | 運動機能を改善する方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240285630A1 (https=) |
| EP (1) | EP4452273A1 (https=) |
| JP (1) | JP2025504706A (https=) |
| CN (1) | CN119072312A (https=) |
| AU (1) | AU2022419178A1 (https=) |
| CA (1) | CA3243958A1 (https=) |
| MX (1) | MX2024007796A (https=) |
| WO (1) | WO2023121689A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TN2017000029A1 (en) | 2014-08-12 | 2018-07-04 | Mezzion Pharma Co Ltd | Methods of improving myocardial performance in fontan patients using udenafil compositions |
| AU2020356193A1 (en) * | 2019-09-24 | 2022-05-19 | Children's Hospital Of Philadelphia | Methods of improving exercise performance, single ventricular performance, and myocardial performance index (MPI) in single ventricle heart disease, using udenafil compositions |
-
2022
- 2022-12-20 CN CN202280092060.3A patent/CN119072312A/zh active Pending
- 2022-12-20 US US17/803,841 patent/US20240285630A1/en active Pending
- 2022-12-20 JP JP2024537409A patent/JP2025504706A/ja active Pending
- 2022-12-20 EP EP22862347.6A patent/EP4452273A1/en active Pending
- 2022-12-20 AU AU2022419178A patent/AU2022419178A1/en active Pending
- 2022-12-20 WO PCT/US2022/000033 patent/WO2023121689A1/en not_active Ceased
- 2022-12-20 CA CA3243958A patent/CA3243958A1/en active Pending
-
2024
- 2024-06-20 MX MX2024007796A patent/MX2024007796A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101653071B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| EP2300001A1 (en) | Dronedarone for the prevention of permanent atrial fibrillation | |
| Madhusoodanan et al. | Clinical experience with quetiapine in elderly patients with psychotic disorders | |
| JP2023540485A5 (https=) | ||
| CN102065855A (zh) | 决奈达隆在制备用于预防因心血管疾病住院或死亡的药物中的用途 | |
| JP2023116697A5 (https=) | ||
| JP2008509224A5 (https=) | ||
| JP2011518147A (ja) | 血中カリウム濃度を調節する薬剤を調製するためのドロネダロンまたは医薬的に許容されるこの塩の使用 | |
| TW589184B (en) | Pharmaceutical composition for preventing or reversing diabetic cardiomyopathy | |
| JP2011522875A (ja) | 電気的除細動を予防するためのドロネダロン | |
| JP2025504706A5 (https=) | ||
| JP5396387B2 (ja) | 心臓不整脈を治療するためのｄ−リボースの用途 | |
| WO2004017973A1 (ja) | 統合失調症治療剤 | |
| JP2022550734A5 (https=) | ||
| JP2011517694A (ja) | ドロネダロンと少なくとも１つの利尿薬の組み合わせおよびこの治療的使用 | |
| CN111467348A (zh) | 一种n-(噻唑-2-基)-3-(哌嗪-1-基)丙酰胺类衍生物在药物制备中的应用 | |
| WO2019004465A1 (ja) | ペマフィブラートを含有する医薬 | |
| Basava et al. | Therapeutic efficacy of carvedilol and hawthorn extract in management of dilated cardiomyopathy in dogs. | |
| JP7312286B2 (ja) | うつ病を予防または治療するための安息香酸またはその塩および誘導体 | |
| JP4733348B2 (ja) | 心不全、他の加齢関連臓器機能不全および加齢関連障害の予防のための、ならびに寿命を延長するための、ナトリウム−水素交換阻害剤であるカリポライドとａｃｅ阻害剤との組み合わせ製剤 | |
| CN120093766A (zh) | 一种用于治疗高血压合并心力衰竭的药物组合物 | |
| Hansson | B028: Study on cognition and prognosis in the elderly (SCOPE). evaluation of risk factors | |
| RU2000102059A (ru) | Способ лечения больных хронической сердечной недостаточностью на фоне ишемической болезни сердца | |
| CN1433302A (zh) | 氢化可的松拮抗剂在治疗心力衰竭中的应用 | |
| JP2002265355A (ja) | 糖尿病由来虚血性心疾患の治療及び／または予防剤 |